Literature DB >> 10449536

Localization of MCC (mutated in colorectal cancer) in various tissues of mice and its involvement in cell differentiation.

T Senda1, A Matsumine, H Yanai, T Akiyama.   

Abstract

Localization of the MCC (mutated in colorectal cancer) gene product, a cell cycle-regulating protein mutated in several colorectal tumors, in various mouse tissues was examined by immunohistochemistry and immunoelectron microscopy. MCC was localized on microvilli and in the apical cytoplasm in renal proximal tubule epithelial cells and pancreatic acinar cells. In hepatocytes, MCC was exclusively detected on microvilli. MCC was highly expressed in the cerebral cortex and the molecular layer of the cerebellar cortex and was partially associated with membrane organelles in neuronal elements. Adrenal chromaffin cells showed little expression of MCC. MCC was localized to the cell margins of ependymal cells, thyroid follicular cells, and anterior pituitary cells. In parotid acinar cells, only the apical surface was immunopositive. MCC was not expressed in skeletal and cardiac muscle. MCC was present at lateral cell borders in the duodenum and colon epithelium. In addition, the apical cytoplasm of colon epithelial cells exhibited intense immunoreactivity. The amount of MCC increased during differentiation of NGF-treated PC12 cells. In conclusion, MCC was expressed in differentiated cells and was associated with the plasma membrane and membrane organelles. In addition to the negative regulation of the cell cycle, MCC may be involved in cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449536     DOI: 10.1177/002215549904700907

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.

Authors:  Laurent Pangon; Nicholas D Sigglekow; Mark Larance; Sam Al-Sohaily; Dessislava N Mladenova; Christina I Selinger; Elizabeth A Musgrove; Maija R J Kohonen-Corish
Journal:  Genes Cancer       Date:  2010-09

2.  Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.

Authors:  R Fukuyama; R Niculaita; K P Ng; E Obusez; J Sanchez; M Kalady; P P Aung; G Casey; N Sizemore
Journal:  Oncogene       Date:  2008-06-30       Impact factor: 9.867

3.  Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.

Authors:  Ruchi Shukla; Kyle R Upton; Martin Muñoz-Lopez; Daniel J Gerhardt; Malcolm E Fisher; Thu Nguyen; Paul M Brennan; J Kenneth Baillie; Agnese Collino; Serena Ghisletti; Shruti Sinha; Fabio Iannelli; Enrico Radaelli; Alexandre Dos Santos; Delphine Rapoud; Catherine Guettier; Didier Samuel; Gioacchino Natoli; Piero Carninci; Francesca D Ciccarelli; Jose Luis Garcia-Perez; Jamila Faivre; Geoffrey J Faulkner
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data.

Authors:  Andrew E Dellinger; Andrew B Nixon; Herbert Pang
Journal:  Cancer Inform       Date:  2014-07-28

5.  Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.

Authors:  Junjie Xiao; Dongchao Lv; Jinzhe Zhou; Yihua Bei; Ting Chen; Muren Hu; Qiulian Zhou; Siyi Fu; Qi Huang
Journal:  Theranostics       Date:  2017-04-10       Impact factor: 11.556

6.  Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes.

Authors:  Shanique K E Edwards; Jacqueline Baron; Carissa R Moore; Yan Liu; David H Perlman; Ronald P Hart; Ping Xie
Journal:  J Hematol Oncol       Date:  2014-09-09       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.